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Choice of a T lymphoid fate by hematopoietic progenitor cells
depends on sustained Notch–Delta signaling combined with tightly
regulated activities of multiple transcription factors. To dissect the
regulatory network connections that mediate this process, we
have used high-resolution analysis of regulatory gene expression
trajectories from the beginning to the end of specification, tests of
the short-term Notch dependence of these gene expression
changes, and analyses of the effects of overexpression of two
essential transcription factors, namely PU.1 and GATA-3. Quanti-
tative expression measurements of >50 transcription factor and
marker genes have been used to derive the principal components
of regulatory change through which T cell precursors progress
from primitive multipotency to T lineage commitment. Our anal-
yses reveal separate contributions of Notch signaling, GATA-3
activity, and down-regulation of PU.1. Using BioTapestry (www.
BioTapestry.org), the results have been assembled into a draft
gene regulatory network for the specification of T cell precursors
and the choice of T as opposed to myeloid/dendritic or mast-cell
fates. This network also accommodates effects of E proteins and
mutual repression circuits of Gfi1 against Egr-2 and of TCF-1 against
PU.1 as proposed elsewhere, but requires additional functions that
remain unidentified. Distinctive features of this network structure
include the intense dose dependence of GATA-3 effects, the gene-
specific modulation of PU.1 activity based on Notch activity, the
lack of direct opposition between PU.1 and GATA-3, and the need
for a distinct, late-acting repressive function or functions to extin-
guish stem and progenitor-derived regulatory gene expression.
GATA-3  Notch  PU.1  T cell development  transcriptional regulation
Exclusion of alternative fates is integral to cell-type specifica-tion and one of the key features explained by the gene
regulatory networks for development in well studied embryo-
logical systems. Cell type-specific gene activation is tightly
coupled with blockade of alternative gene programs, through
three basic elements of gene network architecture: positive
autoregulation of major cell type-specific transcription factors,
feed-forward relationships between these factors and their col-
laborators, and mutual antagonisms between the drivers of
alternative cell fates. The collective impact of these mechanisms
is usually to create within tight spatial and temporal boundaries
a swift cascade of regulatory changes that become effectively
irreversible (1). Yet this is not the only way that cell type
specification can occur. In stem cell-based systems like those in
adult mammals, multipotency is actively maintained over many
cell cycles. Even as differentiation of these precursors begins,
there can be considerable delay before the cell fate decision is
determined. For example, many of the cell fate decisions of
mouse hematopoietic stem cell progeny may be controlled by
dynamic balances of regulatory factors such as PU.1, C/EBP,
and GATA-2 throughout the intermediate stages of the process.
Even in collaboration, these factors appear to drive up to four
different cell fates depending on the ratios and fluxes of their
activities (2, 3). This behavior is a clue that a distinctive gene
network architecture may lie at the core of stem cell-based
cell-type specification.
An extreme case of this mode of specification is mammalian
T lymphocyte development. In T cell specification, cells preserve
a variety of developmental options and a capacity for extensive
proliferation throughout and even after commitment to a T cell
fate. T cell development begins with themigration of multipotent
hematopoietic precursors into the thymus, where these cells
adopt T lineage characteristics and gradually give up the ability
to give rise to other kinds of blood cells. Lineage exclusion is not
only slow but discontinuous for T cell precursors in the thymus:
there is a delay of multiple cell cycles between the time cells lose
certain non-T options (red blood cell, B cell) and the time they
finally become committed to a T cell fate (reviewed in ref. 4).
Unlike B cell specification, a feed-forward cascade with critical
roles for two lineage-specific transcription factors (5), T cell
specification appears to use few, if any, dedicated factors (re-
viewed in refs. 4 and 6). T cell identity emerges through the
combined activities of at least eight, mostly lineage nonspecific,
transcription factors under the influence of Notch pathway
signals from the thymic microenvironment. The challenge has
been to understand the mechanisms operating in this multicom-
ponent system.
Here, we seek to make explicit the regulatory structures and
some aspects of combinatorial control that underlie T lineage
specification in mice. This synthesis combines evidence from: (i)
purifying staged T cell precursors from the stem cell through the
commitment stage; (ii) defining multiple transcription factor
gene expression changes that distinguish these stages in vivo; (iii)
characterizing the impacts of Notch signaling on gene expression
at individual stages, using in vitro culture systems to control
delivery of Notch signals; and (iv) a perturbation analysis based
onmanipulation of two key transcription factors that are thought
to drive opposing network subcircuits in the T cell development
process. We compare the likely inputs of three regulators on the
developmental trajectory of the cells and present a combinato-
rial map of regulatory connections as a testable framework for
reconstructing the full process.
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Results and Discussion
Early T Cell Developmental Progression Through Regulatory Gene
Expression Space. Mouse T cell precursors go through canonical
stages between entry into the thymus and full commitment to the
T cell lineage, distinguishable by changes in surface markers and
quantitatively distinct patterns of gene expression. The same
stages are used in fetal T cell development, adult T cell devel-
opment, and when T cell precursors are induced to differentiate
in stromal culture in vitro, although the kinetics of the progres-
sion differ among fetal, adult, and in vitro development (7–9)
(D.D.S.-A., unpublished data). Cells proliferate in each of the
first two or three stages for several days before moving on to the
next one. Thus, unlike embryonic systems where autonomous
progression from state to state is ‘‘hard-wired’’ in the regulatory
circuitry, T cell specification is inherently discontinuous: pro-
gression between states may depend on repeated microenviron-
mental stimulation (10).
The characteristic gene expression patterns of these stages are
benchmarks for comparison of normal and perturbed versions of
T cell development (Table 1). To represent these complex
changes in a simpler form, we have combined the expression
profiles of 140 genes (7–9, 36) to compute principal compo-
nents of regulatory change across the T lineage specification
process [see supporting information (SI) Text and Tables S1–S4].
For gene expression levels, we used quantitative real-time PCR
data for cells from the earliest, still multipotent intrathymic stage
(DN1 cells) through commitment (to DN3a), and through the
first T cell receptor signaling response, ‘‘-selection’’ (to DN4).
Partial least-squares analysis of the gene expression data was
used to calculate the principal components of variance that best
separate the c-Kit‘‘DN1’’ or ‘‘early T cell precursor’’ (ETP)
stage; the c-Kit CD25 CD44‘‘DN2’’ stage; the CD25
CD44 CD27-low ‘‘DN3a’’ stage; the CD25 CD44
CD27‘‘DN3b’’ stage; and the CD25 CD44‘‘DN4’’ stage (11)
(E.-S.D.-F. and M.A.Y., unpublished work). Tables S2–S4 list
the coordinates for each gene and each stage along axes repre-
senting the first four principal components.
Each developmental stage can be viewed as a unit vector in
one of five orthogonal dimensions. The path connecting the ends
of the five DN-stage vectors in sequential order describes the
developmental trajectory of thymocytes. Projected onto 2D
principal component plots, a DN stage vector appears long if the
selected principal component axes capturemost of the difference
between that DN stage and others. Genes with relatively con-
stant expression are placed near the origin (center of the graph).
Genes with the highest change in expression are furthest from
the center. The more similar the patterns of expression of two
genes, the smaller the angle between them from the center.
Fig. 1A and Fig. S1 show that the first principal component (x
axis) accounts for most of the gene expression differences
between the DN1 and the DN3a/3b stages. The second principal
component (y axis) accounts mostly for differences between
DN3a cells and -selected cells. Subtler changes are captured in
the third and fourth principal components. The first part of the
developmental path toward commitment is nearly parallel to the
first principal component axis, as the cells abandon their use of
prethymically expressed regulatory genes such as Sfpi1 (encod-
ing PU.1), Tal1 (encoding SCL),Gata2, andGfi1b (at the DN1/2
end of the axis). Then, successful T cell receptor expression
triggers a shift along the second principal component axis. The
intermediate DN2 stage involves a distinct excursion along the
third axis (Fig. S1). This trajectory is what should be explained
by transcriptional linkages in a gene regulatory network for T cell
specification. Three vital nodes of the network are examined here.
PU.1 and GATA-3 as Regulatory Inputs. The transcription factors
PU.1 and GATA-3 are both required for early T cell develop-
ment. Loss of either transcription factor from a prethymic stage
virtually eliminates T cell development, but overexpression of
either one in early intrathymic stages is also inhibitory, blocking
the generation of cells capable of undergoing -selection. When
overexpressed, both can push DN thymocytes toward alternative
hematopoietic developmental fates: PU.1 toward the dendritic cell
or monocytic lineages, GATA-3 toward the mast-cell lineage. High
doses of either PU.1 or GATA-3 inhibit particular sets of T cell
genes while activating distinct sets of non-T genes (12–14).
These factors have been expected to oppose one another in T
cell development, based on a key precedent in other blood cell
fate decisions. The related GATA factor GATA-1 and PU.1
apparently act as mutually inhibitory competitive antagonists in
a bistable switch to control the choice between erythroid or
megakaryocytic fates, on the one hand, and all myeloid or
lymphoid cell fates, on the other hand (reviewed in ref. 15–17).
GATA-1 and PU.1 proteins titrate each other’s activities antag-
onistically, while enhancing their own respective expression by
positive transcriptional autoregulation. To adapt such a model to
the genetic requirement for both PU.1 and GATA-3 in T cell
development, PU.1 might support gene expression associated
Table 1. Gene expression changes marking transitions in T-cell development
Gene category
Initiation,
stem to DN1
increase
DN2 entry,
DN1 to DN2
increase
Specification,
DN1–DN3 continuous Commitment, DN3 stage -Selection
Increase Decrease Increase Decrease Increase Decrease
Transcription factors GATA-3 Bcl11b GATA-3 PU.1 Ets2 PU.1 Aiolos SpiB
TCF-1 HEB-alt TCF-1 (Tcf7) SCL Pou6f1 SCL SATB1 HES1
HES1 HEB (Tcf12) GATA-2 SpiB Tbet Myb
Ikaros Id2 HES1 Runx1
Gfi1 Runx2 LEF-1 HEB-alt
Runx1 Runx3 Id3 Erg
Ets1 Gfi1B Id2
C/EBP (and others)
(& others)
Targets/other Deltex1 CD3 IL-7R Mac-1 Deltex1 c-Kit TCR-C Deltex1
CD3 CD25 pT (Ptcra) IL-7R
Rag-1 Rag-1 pT (Ptcra)
CD3 Notch3 Rag-1
Lck Lck CD25
LAT LAT ZAP70 Bcl2
ZAP70 ZAP70 Notch1
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with ‘‘immaturity,’’ whereas GATA-3 could promote gene ex-
pression associated with T lineage commitment. The expression
patterns and functions of PU.1 and GATA-3 are indeed diver-
gent (6, 8, 9, 18): from a high initial level of expression, PU.1 is
sharply and permanently down-regulated during T lineage com-
mitment (DN1–DN3a) in vivo, whereas GATA-3 rises gradually
and functions repeatedly throughout T cell development (Table
1). These expression patterns fall near opposite ends of the first
principal component axis in Fig. 1A; analyzing detailed impacts
of exogenous PU.1 or GATA-3 should detect whether opposition
between these two factors actually controls the position of cells
along this axis.
As T cell development is blocked when either PU.1 or
GATA-3 is overexpressed, and because either factor at high level
can sequester the other, double overexpression experiments may
not prove that antagonism is relevant in vivo. However, if PU.1
and GATA-3 did titrate each other in normal thymocytes, each
should normally be limiting the other’s activity during the DN1
and DN2 stages when both are present. Then, experimentally
increased expression of either factor should oppose the distinc-
tive pattern of gene expression effects attributable to the other
factor (Fig. 1 B and C). The magnitudes of the PU.1 and
GATA-3 effects and the statistical significances determined by
ANOVA are shown in Fig. S2 and Tables S5 and S6 (negative T
statistic values indicate repression). Fig. 1 B–E show interactions
that exceed a P value threshold of 0.05 (after correction for
multiple hypothesis testing).
The overexpression effects of PU.1 generally oppose the
trends of DN1 to DN3a differentiation (Fig. 1C), as PU.1
represses a wide range of genes used in theDN3 stages. Although
these may not all be direct targets, they support the idea that
high-level endogenous PU.1 in the DN1 stage could help to delay
gene expression changes associated with T lineage progression,
perhaps to allow continued self-renewal. Conversely, high-level
GATA-3 does increase expression of a T lineage supporting
gene, Hes1, and also represses PU.1 (Sfpi1) RNA expression in
thymocytes (12, 14, 19)(Fig. 1B). This effect is confirmed by
GATA-3 loss-of-function phenotype (D.D.S.-A., unpublished
work) and by effects of GATA-3 coexpression with a PU.1
cis-regulatory sequence reporter in myeloid cells (M.A.Z., un-
published work). Although additional regulatory inputs are
likely needed to explain the steepness of PU.1 repression in
thymocytes (20, 21) (M.A.Z., unpublished work), GATA-3 may
be a substantial contributor to the repression mechanism.
However, high-level GATA-3 does not show other effects
expected for a T lineage promotion factor. Even setting aside its
activation of ‘‘non-T’’ mast cell genes (14) and focusing on T
lineage genes only, many effects of high-level GATA-3 also
oppose DN3a-specific gene expression (Fig. 1B). Consider T cell
genesMyb, Gfi1, Cd3e, Lck, LAT, Rag1, Tcf7 (encoding TCF-1),
Ets1, and Ets2, which are induced from DN1 to DN3a (Table 1).
All of these genes are down-regulated by exogenous high-level
PU.1, but not enhanced by higher GATA-3: they are either
unaffected or frankly down-regulated by high-level GATA-3 as
well. Furthermore, Lef1, another DN3-stage up-regulated gene,
is actually inhibited by GATA-3 but unaffected by PU.1. Two
additional features of the PU.1: GATA-3 subnetwork contrast
with those of PU.1/GATA-1 interaction. First, PU.1 shows little
or no ability to inhibitGATA-3 expression in thymocytes (13).Also,
GATA-3 cannot enhance its own expression in these cells (14).
These data imply that the relationship between PU.1 and
GATA-3 in T cell development differs from the bistable switch
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Fig. 1. Gene expression changes during normal T lineage specification and regulatory perturbation: depiction in principal component space. (A) Coordinates
of key genes (black or magenta stars) and gene expression signatures of DN1, DN2, DN3a, DN3b, and DN4 stages, projected on axes representing the first two
principal components of gene expression change (full data in Fig. S1 and Tables S2–S4). (B) Targets of GATA-3 overexpression in fetal thymocytes, positioned
relative to first two principal component axes shown in A (14). The coordinates of the normal, adult DN1–DN4 phenotypes are shown for orientation by blue
vectors. Genes positively affected by GATA-3 overexpression are targets of green arrows, with negatively affected genes indicated by red arrows. (C) Targets of
PU.1 overexpression in fetal thymocytes (13), depicted as in B. (D) Effects of short-term exposure to Notch–Delta signaling in fetal thymocytes. These effects,
compiled from refs. 13 and 14, are calculated independently of effects of PU.1 or GATA-3 in the experiments. (E) Supraadditive modulation of PU.1 effects by
Notch–Delta signaling (P  0.05; Tables S5 and S6). Genes that are protected from repression supraadditively by Notch–Delta signaling are shown in green. A
gene that is prevented from up-regulation by Notch–Delta signaling is shown in red.
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model imputed to PU.1 and GATA-1. If GATA-3 promotes
progression to DN3a, it probably does so not by titrating PU.1
directly to relieve PU.1 repression of T cell genes, but rather by
helping to repress transcription of PU.1 itself. GATA-3 clearly
provides other unique regulatory functions for early T cell
development, but these are likely governed by essential GATA-3
dose–response requirements at specific target genes rather than
by opposition of GATA-3 to PU.1.
Notch–Delta Signaling as a Direct Regulator of T Lineage Specification
Genes. T cell specification depends completely on Notch pathway
triggering by interaction with Delta-class ligands in the environ-
ment. Notch–Delta signaling is needed from the earliest DN1
stage through commitment and into -selection. Some of its
most direct effects are seen by incubating defined populations of
immature thymocytes with stromal cells that either do (OP9-
DL1) or do not (OP9-control) express Delta (22), then reiso-
lating the thymocytes and measuring gene expression. Results
from experiments that measured these effects and PU.1 or
GATA-3 effects are shown in Fig. S3. Fig. 1D shows that many
of the regulatory effects, direct and indirect, of Notch–Delta
signaling in thymocytes are to activate genes associated with the
DN3–DN4 stages. The aggregate effects of Notch signaling on
gene expression broadly appear ‘‘opposite’’ to those of PU.1
overexpression in Fig. 1C. Thus Notch–Delta signaling appears
to be more closely associated with DN3-specific regulatory
events than does GATA-3 (Fig. 1B).
Is the DN3a stage phenotype then simply a reflection of
increasing activation of direct Notch target genes or must
additional factors play a rate-limiting role? Fig. 2 shows a direct
comparison of the developmental regulation and Notch–Delta
dependence of multiple thymocyte genes; additional data are
shown in Fig. S3. In Fig. 2, ratios of gene expression in DN3a to
DN1 are shown in order of highest to lowest DN3 up-regulation
(line graphs: results in two independent experiments) (7, 8), with
the effects of short-term Notch signaling on the same genes
superimposed (bars) (13, 14). The patterns do not match. Known
direct Notch target genes Deltex1, Hes1, and Ptcra (T cell
receptor surrogate  chain, pre-T) that peak in expression at
the DN3a stage are strongly affected by Notch–Delta interac-
tion. However, this is not true for other T lineage genes, such as
the regulatory genes Gata3 and Bcl11b, and the genes encoding
T cell receptor complex proteins Cd3g and Cd3e (8, 9). These
genes, too, are only induced in hematopoietic precursors through
aNotch-dependent regulatory cascade (9, 23), but once activated
in Thy-1 thymocytes (DN2 stage or beyond), these landmark
genes and others with maximal expression at the DN3a stage
become much less dependent on Notch–Delta interaction (Fig.
2). Thus, regulatory inputs besides Notch (and GATA-3) control
the gene expression trajectory through the DN2 and DN3 stages,
and these must be included in a T cell gene regulatory network.
Modification of Regulatory Factor Effects by Interactions with Notch.
Notch signaling makes another kind of contribution to the
regulatory state of the developing cells: to modulate the effects
of other regulators in a gene-specific and factor-specific way. In
prethymic hematopoietic precursors, Notch signaling synergizes
with the effects of the basic helix—loop—helix factor E2A to
enhance activation of T lineage-associated genes such as Ptcra
(24). In fetal thymocytes, Notch signaling modulates the effects
of PU.1 selectively to relieve its repression of T lineage genes
(13). Note that cells can receive both Notch and PU.1 regulatory
inputs independently without direct antagonism. Notch–Delta
signaling does not repress Sfpi1 (PU.1) itself, and even at high
levels PU.1 in thymocytes does not inhibit expression of Notch1
or Notch3, nor interfere with Notch–Delta-dependent induction
of Ptcra or Deltex1. However, when effects of PU.1 are assessed
in the presence or absence of Notch–Delta signaling, a statisti-
cally strong interaction is seen, such that Notch/Delta signals
block PU.1 effects on many genes.
Of 23 early T cell genes affected by PU.1 in our analysis, as
many as 11 of them (Myb, Hes1, Ikzf1, Gfi1, Cd3e, Rag1, Lat,
Bcl11b, Zap70, Ets1, and Tcf12) were protected supraadditively
from PU.1 by Notch–Delta signals (P  0.05; Fig. 1E and Table
S5). In addition, Id2 was blocked from induction by PU.1 by
Notch–Delta signals at P  0.06. The Notch-protected genes
were particularly associated with the DN3 states, and the inter-
action was specific, because it did not apply to other genes
regulated by PU.1 and Notch, such as genes associated with
myeloid lineage redirection (13). In contrast, effects of high-level
GATA-3 were less influenced by Notch signaling. Of 22 early T
lineage genes affected by GATA-3, Notch–Delta signaling only
modified three in a supraadditive way, reducing the positive
effects of GATA-3 on Hes1 and Mitf and protecting Tcf7 from
repression (Table S6).
Thus, PU.1 effects on the progression of thymocytes from
DN1 to DN3a can only be evaluated in relation to the status of
Notch signals, whereas GATA-3 effects essentially depend on
level.
Assembly of a Framework for the T Cell Specification Gene Regulatory
Network. We have used BioTapestry software (www.BioTapestry.
org) (25) to make explicit the network of regulatory relationships
that appear to operate as committed early T cell precursors emerge
from hematopoietic stem cells and other pluripotent progenitors.
Such a network integrates the available data on regulatory inputs
into each of the important genes in a process. It provides a
validation map for assessing to what extent available information
can account for the pattern of expression of individual genes and for
the coordination of expression of groups of genes through the
course of the process. Although yet incomplete, this network
provides a useful armature for the regulatory relationships involved
in T cell specification.
To construct this model, we have combined gene expression
data for normal thymocyte subsets and perturbation data for
PU.1, GATA-3, and Notch regulatory effects. Because PU.1 and
GATA-3 can promote lineage redirection to myeloid/dendritic
and mast-cell fates, respectively, regulatory pathways involved in
these fate alternatives (26, 27) are also included. Also incorpo-
rated is evidence from the literature on some additional Notch
inputs (28), possible linkages both upstream [TCF-1 (Tcf7),
Runx (20, 21)] and downstream [Gfi1, Egr2 (2)] of PU.1, and
additional data on changes in gene expression that follow
commitment, during TCR-dependent selection in the DN3b and
DN4 stages (8, 11, 29). Of special interest are also connections
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Fig. 2. Direct Notch regulation of early T cell genes compared with devel-
opmental regulation during the DN1 to DN3 transitions. Line graphs show the
log10 of the ratio of expression of indicated genes in adult DN3a cells relative
to DN1 cells in two independent studies (7, 8) (E.-S.D.-F. and M.A.Y., unpub-
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Notch–Delta signaling on gene expression in Thy-1 embryonic day 15.5 fetal
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additional results see Fig. S3. Data are from empty vector controls in ref. 13.
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involving the basic helix—loop—helix E proteins. These con-
tribute to the DN3 stage checkpoint, TCR gene rearrangement,
and inhibition of alternative NK and myeloid fates (24, 30–35).
A static view of this BioTapestry network is shown in Fig. 3.
Full-sized screen shots and full annotation of the individual links
are provided in Fig. S4 and Table S7. In the interactive BioTap-
estry viewer posted on line (www.its.caltech.edu/tcellgrn), we
also provide dynamic views of changing network states through
the DN1 to DN4 transitions, all of the raw data from our group’s
publications on which the network links are based, and contin-
uous updating of the annotations of data for individual links.
The biology of this system has required three modifications of
the usual gene regulatory network depiction (25). First, the
effects of Notch signaling on the activities of other regulators
have had to be taken into account. Besides the independent
cis-regulatory inputs of Notch and its transcription factor CSL,
our results require ‘‘processing’’ of the effects of transcription
factors such as PU.1 by some agents of Notch–Delta signaling.
Second, GATA-3 is a particularly stark case showing that the
same factors make different network links when expressed at
different concentrations. For example, GATA-3 at high level
shuts off Il7ra, which is normally coexpressed with Gata3, while
it induces other genes (Tal1, Gata2, Gfi1b) that would normally
be turned off at stages when Gata3 expression peaks.
Third, the data reviewed above identifies three obvious gaps
in using Notch, GATA-3, PU.1, or other known factors, to
account for T cell development. These have been filled by
‘‘placeholders.’’ A specification inducer, not Notch/CSL itself, is
needed to account for the first up-regulation of Bcl11b, HEBalt,
and the Cd3 genes at the DN2 stage. A DN3-specific gene
activator seems necessary, beyond known effects of Notch
signaling (Fig. 2) and E protein activity (24, 30, 32), to account
for the full pattern of DN3a-stage gene activation. Finally, a
repressive T lineage commitment function is needed to account
for the timing of repression of Sfpi1, Tal1,Gfi1b, and other non-T
lineage-promoting regulatory genes during the DN2 to DN3
transition. By placing these functions in a network context,
regulatory pathways involving known factors may be discovered
that are equivalent to those involving these placeholders, and
thus help to establish the molecular identities of these agents.
Concluding Remarks
T cell specification is not governed by a few dedicated transcrip-
tion factors operating in a simple regulatory pathway. It can only
Fig. 3. Gene regulatory network model for T cell specification. (A) View from all nuclei: comprehensive map of relationships included in the network,
integrating over all stages. For sources of each link, see Table S7. For expanded size figure, see Fig. S4A. For predicted differential activity of different network
links at different stages, see Fig. S4 G–K. (B) Close-ups of one region of the network with background highlighting indicating differential gene expression levels
at five different developmental states. For full network versions, see Fig. S4 B–F.
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be understood in gene network terms. It depends on multiple
transcription factors, almost every one of which is also used, in
other combinations, for other hematopoietic programs. The
close linkage of T cell development to other hematopoietic fates
is hammered home by the ease of diverting T cell precursors to
other lineages, when the same transcription factors that are
normally part of the T cell program are overexpressed. This
sharing is typical for hematopoietic lineage decisions, in which
the same transcription factors expressed in different ratios or in
different temporal orders yield different cell types.
However, this kind of system also makes gene network construc-
tion difficult. The regulatory meaning of every transcription factor
completely depends on level and context. To explain how factors
like GATA-3 can be used for T cell development at all, it has been
crucial to build into the network diagramdose-sensing nodes, which
channel transcription factor input to different downstream genes at
high factor levels than at low factor levels. Such nodes are not
commonly needed in the embryonic specification gene networks
developed to date, where transcription factors can act in a quasi-
Boolean way because of strongly forward-driving network archi-
tecture. For T cell development, a most important part of the
context is provided by Notch pathway signaling throughout T cell
specification. Notch not only provides its own transcriptional input
but also modifies the effects of both high-level GATA-3 and PU.1.
Thus, to explain the use of PU.1, it has been crucial to include a
node for filtering this transcription factor’s regulatory effects
through transformations, still poorly understood, that depend on
Notch–Delta signaling.
The network presented here is a framework, not a complete
solution. Only a limited number of perturbations have been
tested so far in the temporally defined and stage-specific way that
is needed to discern proximal downstream regulatory targets.
The ultimate goal of explaining biology on the basis of internal
network structure must await identifying the targets of other
regulators. Also, as we have emphasized, there are a number of
stage-specific functions required for T cell development that
remain to be identified, as they cannot be accounted for by
effects of Notch signaling or GATA-3, and do not appear to be
explained by the expression patterns of other known factors. Two
positive T lineage-promoting functions are needed at different
stages, and at least one lineage exclusion function is needed for
commitment. Whether these are mediated by single factors or
network subcircuits remains to be defined. The network arma-
ture developed here nevertheless shows just where additional
regulators must be invoked. The completion of these links will
ultimately reveal how the architecture of the T cell network
explains the distinctive mode of T lineage specification.
Materials and Methods
See full materials and methods in SI Text. Regulatory and marker gene
expression was measured by quantitative real-time PCR as described (7, 9, 29).
Four representative sample series of DN subsets were used for Fig. 1. Expres-
sion levels were normalized to -actin expression in the same samples, log10
transformed, and then submitted to partial least squares analysis and ANOVA
(corrected for multiple hypothesis testing) as described in SI Text.
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